FDA Approves Pradaxa® (dabigatran etexilate mesylate) for Treatment and Reduction in the Risk of Recurrence of Deep Venous Thrombosis and Pulmonary Embolism Three pivotal trials showed PRADAXA as ...
The Food and Drug Administration has approved a new indication for Boehringer Ingelheim’s Pradaxa (dabigatran etexilate) oral pellets. The drug now is indicated to treat children ages 3 months to less ...
Ridgefield, CT, April 6, 2015 – Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) filed a supplemental New Drug Application (sNDA) for ...
Abstract sphere from a blood clot cells background. Scientific and medical microbiological concept. Enrichment with oxygen and important nutrients. Transfer of important elements, 3d illustration ...
Pradaxa label updated with contraindication The anticoagulant dabigatran etexilate mesylate should not be used in patients with mechanical prosthetic heart valves, the FDA warns. HealthDay News – The ...
SILVER SPRING, MD (updated, corrected) — A massive study of Medicare patients at risk of stroke secondary to atrial fibrillation (AF) has found no signal of increased MI risk with dabigatran (Pradaxa, ...
Boehringer Ingelheim announced that the Food and Drug Administration (FDA) has granted full approval for Praxbind (idarucizumab) for use in patients treated with Pradaxa (dabigatran etexilate mesylate ...
SILVER SPRING, Md. The Food and Drug Administration approved a drug for preventing strokes and blood clots in patients with abnormal heart rhythm, the agency said Tuesday. The FDA announced the ...
Boehringer Ingelheim is accusing The British Medical Journal (BMJ) of making “misleading statements” after the journal published an article and an editorial critical of the company’s pursuit of ...
[{ "name": "Inline Story Links", "component": "11821434", "insertPoint": "4th", "startingPoint": 3, "requiredCountToDisplay": "3", "maxInsertions": 5 },{ "name ...
RIDGEFIELD, Conn., April 8, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Pradaxa ® (dabigatran ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback